These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15078103)

  • 21. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
    Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
    J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity.
    Al Adem K; Ferreira JC; Fadl S; Rabeh WM
    J Biol Chem; 2023 Feb; 299(2):102790. PubMed ID: 36509143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris.
    Nguyen TT; Woo HJ; Kang HK; Nguyen VD; Kim YM; Kim DW; Ahn SA; Xia Y; Kim D
    Biotechnol Lett; 2012 May; 34(5):831-8. PubMed ID: 22350287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure.
    Hu T; Zhang Y; Li L; Wang K; Chen S; Chen J; Ding J; Jiang H; Shen X
    Virology; 2009 Jun; 388(2):324-34. PubMed ID: 19409595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant.
    Akaji K; Konno H; Onozuka M; Makino A; Saito H; Nosaka K
    Bioorg Med Chem; 2008 Nov; 16(21):9400-8. PubMed ID: 18845442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition.
    Han YS; Chang GG; Juo CG; Lee HJ; Yeh SH; Hsu JT; Chen X
    Biochemistry; 2005 Aug; 44(30):10349-59. PubMed ID: 16042412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease.
    Wu CG; Cheng SC; Chen SC; Li JY; Fang YH; Chen YH; Chou CY
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):747-55. PubMed ID: 23633583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.
    Yang H; Yang M; Ding Y; Liu Y; Lou Z; Zhou Z; Sun L; Mo L; Ye S; Pang H; Gao GF; Anand K; Bartlam M; Hilgenfeld R; Rao Z
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13190-5. PubMed ID: 14585926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiolate-imidazolium ion pair is not an obligatory catalytic entity of cysteine peptidases: the active site of picornain 3C.
    Sárkány Z; Szeltner Z; Polgár L
    Biochemistry; 2001 Sep; 40(35):10601-6. PubMed ID: 11524003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis.
    Ding L; Zhang XX; Wei P; Fan K; Lai L
    Anal Biochem; 2005 Aug; 343(1):159-65. PubMed ID: 15935325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The substrate specificity of SARS coronavirus 3C-like proteinase.
    Fan K; Ma L; Han X; Liang H; Wei P; Liu Y; Lai L
    Biochem Biophys Res Commun; 2005 Apr; 329(3):934-40. PubMed ID: 15752746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic activity of the SARS coronavirus main proteinase dimer.
    Graziano V; McGrath WJ; DeGruccio AM; Dunn JJ; Mangel WF
    FEBS Lett; 2006 May; 580(11):2577-83. PubMed ID: 16647061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A mutations on the extra domain.
    Lim L; Shi J; Mu Y; Song J
    PLoS One; 2014; 9(7):e101941. PubMed ID: 25036652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
    Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.
    Shie JJ; Fang JM; Kuo CJ; Kuo TH; Liang PH; Huang HJ; Yang WB; Lin CH; Chen JL; Wu YT; Wong CH
    J Med Chem; 2005 Jun; 48(13):4469-73. PubMed ID: 15974598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds.
    Lee CC; Kuo CJ; Ko TP; Hsu MF; Tsui YC; Chang SC; Yang S; Chen SJ; Chen HC; Hsu MC; Shih SR; Liang PH; Wang AH
    J Biol Chem; 2009 Mar; 284(12):7646-55. PubMed ID: 19144641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.
    Chen LR; Wang YC; Lin YW; Chou SY; Chen SF; Liu LT; Wu YT; Kuo CJ; Chen TS; Juang SH
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3058-62. PubMed ID: 15896959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease.
    Shi J; Sivaraman J; Song J
    J Virol; 2008 May; 82(9):4620-9. PubMed ID: 18305031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
    Ferreira JC; Fadl S; Villanueva AJ; Rabeh WM
    Front Chem; 2021; 9():692168. PubMed ID: 34249864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts.
    Luo W; Su X; Gong S; Qin Y; Liu W; Li J; Yu H; Xu Q
    Biosci Trends; 2009 Aug; 3(4):124-6. PubMed ID: 20103835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.